Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
10/28/2004 | CA2522205A1 Process for preparing macrocyclic compounds |
10/28/2004 | CA2521831A1 Benzoxepino-11-piperidylidene compounds and process for production thereof |
10/28/2004 | CA2521810A1 Substituted quinobenzoxazine analogs |
10/28/2004 | CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
10/27/2004 | EP1471068A1 Process for total synthesis of ecteinascidins and intermediates therefor |
10/27/2004 | EP1470129A2 Radiolabeled neuropeptide y y5 receptor antagonists |
10/27/2004 | EP1470128A1 Intermediates for preparing glycogen phosphorylase inhibitors |
10/27/2004 | EP1470126A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor |
10/27/2004 | EP1470125A1 Aminopiperidine derivatives |
10/27/2004 | EP1469854A1 Condensed heterocyclic compounds |
10/27/2004 | EP1469809A2 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
10/27/2004 | EP0858996B1 Nerve cell protective agents |
10/27/2004 | CN1541219A Tricyclic imidazopyridines |
10/27/2004 | CN1541214A Novel compounds |
10/27/2004 | CN1172935C High-efficient production method for 10-hydroxycamptothecine |
10/27/2004 | CN1172917C Steroid receptor modulator compounds and methods |
10/26/2004 | US6809202 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
10/26/2004 | US6809105 Diazabicyclic central nervous system active agents |
10/26/2004 | US6809103 E-ring expanded camptothecin derivatives |
10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
10/21/2004 | WO2004089949A1 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands |
10/21/2004 | WO2004089939A1 Condensed furan derivatives as adenosine antagonists |
10/21/2004 | WO2004089931A1 Substituted pyrazoles |
10/21/2004 | WO2004089926A2 Genipin derivatives and uses thereof |
10/21/2004 | WO2004089307A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
10/21/2004 | WO2004058144A3 Antibacterial agents |
10/21/2004 | WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
10/21/2004 | US20040209934 Protein phosphate inhibitors |
10/21/2004 | US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
10/21/2004 | US20040209871 Fused bicyclic nitrogen-containing heterocycles |
10/21/2004 | US20040209864 Substituted heterocycle fused gamma-carbolines |
10/21/2004 | US20040209846 Heterocyclic analgesic compounds and methods of use thereof |
10/21/2004 | CA2521201A1 Substituted pyrazoles for use in the prophylaxis or treatment of a disease which can be influenced by the binding of the substitued pyrazoles to 5ht receptors |
10/21/2004 | CA2520114A1 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
10/20/2004 | EP1467997A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
10/20/2004 | EP1467993A1 Method for producing scopine esters |
10/20/2004 | EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION |
10/20/2004 | EP1467975A1 Substituted alkyl uracils and the use thereof |
10/20/2004 | EP1467723A1 Phenyl sulfoxides and phenyl sulfones |
10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
10/20/2004 | CN1538956A Spiro compounds |
10/20/2004 | CN1538846A Oral administration of 6-hydroxy-oxymorphone for use as antalgesic |
10/20/2004 | CN1171893C Microencapsulated lewis acid |
10/20/2004 | CN1171887C Respiratory syncytial virus replication inhibitors |
10/20/2004 | CN1171871C 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
10/19/2004 | US6806312 Thermoplastic resin composition |
10/19/2004 | US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects |
10/19/2004 | US6806283 Selective serotonin receptor antagonists and therapeutic applications thereof |
10/19/2004 | US6806264 Arylphenyl-substituted cyclic ketoenols |
10/19/2004 | CA2296901C Piperidine derivates having anxiolytic effect |
10/14/2004 | WO2004087715A1 Process for preparing topotecan from 10-hydroxy-4-(s) camptothecin |
10/14/2004 | WO2004087701A1 Cyclic benzimidazoles |
10/14/2004 | WO2004087145A2 Antibacterial agents |
10/14/2004 | WO2004087056A2 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ |
10/14/2004 | WO2004078116A3 P38 inhibitors and methods of use thereof |
10/14/2004 | US20040204584 Alzheimer's disease; Parkinson's disease; antidepressants |
10/14/2004 | US20040204421 Certain 1,3-disubstituted isoquinoline derivatives |
10/14/2004 | US20040204397 Calcitonin gene related peptide receptor antagonists |
10/14/2004 | US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders |
10/14/2004 | US20040204317 fluorescein dyes that exhibit a first color when in the crystal structured form and a second color when in the liquid, amorphous form, for use in thermal printing |
10/14/2004 | US20040200388 Perylene-derivative based crystallization modifiers |
10/14/2004 | DE10315572A1 Substituierte Pyrazole Substituted pyrazoles |
10/14/2004 | CA2520581A1 Cyclic benzimidazoles |
10/14/2004 | CA2520465A1 Bi-cyclic pyrimidine inhibitors of tgf.beta. |
10/13/2004 | EP1465900A1 Rho-kinase inhibitors |
10/13/2004 | EP1465896A2 Mitotic kinesin inhibitors |
10/13/2004 | EP1465895A2 4-oxo-4,7-dihydrofuro(2,3-b)pyridine-5-carboxamide antiviral agents |
10/13/2004 | EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
10/13/2004 | EP1465630A1 Cyclic urea derivatives with 5-ht2c receptor activity |
10/13/2004 | EP1465625A2 Solubilized topoisomerase poisons |
10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |
10/13/2004 | EP1381615B1 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- [1,4]DIOXINO[2,3-e]INDOLE |
10/13/2004 | EP1211253B1 Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents |
10/13/2004 | EP1169038A4 Cyclic protein tyrosine kinase inhibitors |
10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
10/13/2004 | CN1537016A Remedies for psychoneurosis |
10/13/2004 | CN1535969A Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application |
10/13/2004 | CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound |
10/13/2004 | CN1535956A Substituted phenyl keto-enol pesticide and weedicide |
10/13/2004 | CN1535682A Medicine for improved bladder excretion capacity |
10/13/2004 | CN1170830C Prepn. of levo-ofloxacin |
10/12/2004 | US6803471 Useful as photochromic compounds; covalently attached to wang resins and method of attaching; ophthalmic lenses |
10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
10/12/2004 | US6803368 Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalene |
10/12/2004 | US6803129 Organic light emitting diode and organic luminescent materials thereof |
10/12/2004 | CA2387401C Compositions, methods and systems for the production of enediynes |
10/07/2004 | WO2004085440A1 Benzofuro-1,4-diazepin-2-one derivatives |
10/07/2004 | WO2004085428A1 A new process for preparing olmesartan medoxomil |
10/07/2004 | WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
10/07/2004 | WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk |
10/07/2004 | WO2004075823A3 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
10/07/2004 | WO2003068748A9 Novel pyridine- and quinoline-derivatives |
10/07/2004 | US20040198981 Tricyclic dihydroquinoline derivatives,method for preparing same and pharmaceutical compositions containing same |
10/07/2004 | US20040198980 Selective rxr ligands |
10/07/2004 | US20040198808 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
10/07/2004 | US20040198791 Fused imidazole derivative |
10/07/2004 | US20040198764 Prodrugs of imidazopyridine derivatives |
10/07/2004 | US20040198760 Anticancer agents ; skins, prostate glands, lungs, breasts, leukemia, central nervous system, colon |
10/07/2004 | US20040198759 Aporphine and oxoaporphine compounds and pharmaceutical use thereof |